Yes-associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1-rearranged lung cancer.
Cancer Sci
; 114(2): 546-560, 2023 Feb.
Article
in En
| MEDLINE
| ID: mdl-36285485
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Cancer Sci
Year:
2023
Document type:
Article
Affiliation country:
Japan
Country of publication:
United kingdom